title: Contrast-medium-induced ventricular fibrillation: arrhythmogenic mechanisms and the role of antiarrhythmic drugs in dogs.
authors.forename: J M
authors.initials: JM
authors.lastname: Idée
authors.forename: C
authors.initials: C
authors.lastname: Matalon
authors.forename: B
authors.initials: B
authors.lastname: Koeltz
authors.forename: B
authors.initials: B
authors.lastname: Bonnemain
authors.forename: T
authors.initials: T
authors.lastname: Lefevre
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D003287:Contrast Media / Q000009:adverse effects* / Q000737:chemistry / Q000494:pharmacology; D004285:Dogs; D004562:Electrocardiography / Q000187:drug effects; D007472:Iohexol / Q000009:adverse effects* / Q000737:chemistry / Q000494:pharmacology; D007485:Ioxaglic Acid / Q000009:adverse effects; D009994:Osmolar Concentration; D011817:Rabbits; D012964:Sodium / Q000008:administration & dosage / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents; D003287:Contrast Media; D007472:Iohexol; D012964:Sodium; D007485:Ioxaglic Acid